Abstract:Hematopoietic stem cell (HSC) homeostasis is controlled by cytokine receptor-mediated Janus kinase 2 (JAK2) signaling. We previously found that JAK2 is promptly ubiquitinated upon cytokine stimulation. Whether a competing JAK2 deubiquitination activity exists is unknown. LNK is an essential adaptor protein that constrains HSC expansion through dampening thrombopoietin (TPO)-induced JAK2 signaling. We show here that a LNK-associated lysine-63 (K63)-deubiquitinating enzyme complex, Brcc36 isopeptidase complex (BRISC), attenuates HSC expansion through control of JAK2 signaling. We pinpoint a direct interaction between the LNK SH2 domain and a phosphorylated tyrosine residue in KIAA0157 (Abraxas2), a unique and defining BRISC component. Kiaa0157 deficiency in mice led to an expansion of phenotypic and functional HSCs. Endogenous JAK2 and phospho-JAK2 were rapidly K63-ubiquitinated upon TPO stimulation, and this action was augmented in cells depleted of the BRISC core components KIAA0157, MERIT40, or BRCC36. This increase in JAK2 ubiquitination after BRISC knockdown was associated with increased TPO-mediated JAK2 activation and protein levels, and increased MPL receptor presence at the cell surface. In addition, BRISC depletion promoted membrane proximal association between the MPL receptor and pJAK2/JAK2, thus enhancing activated JAK2/MPL at the cell membrane. These findings define a novel pathway by which K63-ubiquitination promotes JAK2 stability and activation in a proteasome-independent manner. Moreover, mutations in BRCC36 are found in clonal hematopoiesis in humans. This research may shed light on the mechanistic understanding of a potential role of BRCC36 in human HSCs.

Differential Regulation of Jamm Domain Deubiquitinating Enzyme Activity Within the Rap80 Complex

K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1

The Rap80-BRCC36 De-Ubiquitinating Enzyme Complex Antagonizes RNF8-Ubc13-dependent Ubiquitination Events at DNA Double Strand Breaks

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

MERIT 40 Controls BRCA 1 – Rap 80 Complex Integrity and Recruitment to DNA Double-Strand Breaks

RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response

Histone Ubiquitination Associates With Brca1-Dependent Dna Damage Response

Ubc13/Rnf8 Ubiquitin Ligases Control Foci Formation Of The Rap80/Abraxas/Brca1/Brcc36 Complex In Response To Dna Damage

A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.

Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair.

The BRISC Deubiquitinating Enzyme Complex Limits Hematopoietic Stem Cell Expansion by Regulating JAK2 K63-ubiquitination.

The FHA and BRCT Domains Recognize ADP-ribosylation During DNA Damage Response.

Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair.

DRJAMM is Involved in the Oxidative Resistance in Deinococcus Radiodurans

Structure and functional determinants of Rad6-Bre1 subunits in the histone H2B ubiquitin-conjugating complex

RAP80 Protein is Important for Genomic Stability and is Required for Stabilizing BRCA1-A Complex at DNA Damage Sites in Vivo.

CRL4Wdr70 Regulates H2B Monoubiquitination and Facilitates Exo1-dependent Resection

Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response.

The deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cells

Molecular glues that inhibit deubiquitylase activity and inflammatory signalling